Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 298 for “"IAP"”.
-
Charakterisierung von BRUCE als antiapoptotisches IAP
… herbeiführen. Apoptose wird durch pro- und antiapoptotische Proteine reguliert, die die Aktivierung von Caspasen stimulieren bzw. unterdrücken. Da diese Proteine sich gegenseitig beeinflussen, wird das Schicksal einer Zelle durch die relative Aktivität pro- und antiapoptotischer Faktoren …
-
The Inhibitor of Apoptosis (IAP) Ubiquitome
The Inhibitor of Apoptosis (IAP) proteins are a highly conserved group of anti-apoptotic proteins. Cellular IAP 1 and 2 (cIAP1 and 2) are two members of the IAP protein family that regulate the activity of the Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcription …
-
IAP antagonist Grim mediates cell death through divergent pathways
… or developmental cues, inhibitor of apoptosis (IAPs) can prevent caspase-mediated cell death, not only through direct binding and inhibition, but also by directly ubiquitinating caspases, which inactivates them or targets them for degradation. In flies and mammals, cell death is facilitated or …
-
Regulation of effector caspases by inhibitor of apoptosis (IAP) proteins
… of living organisms. Inhibitor of apoptosis (IAP) proteins are endogenous inhibitors of caspases, and since XIAP, the prototypical IAP, binds to and inhibits caspases, all IAPs have been speculated to engage in similar inhibition mechanisms. However, in this dissertation, I demonstrate that …
-
The Panther University International Accelerator Program (IAP) A Program Evaluation
… on how the International Accelerator Program (IAP) affected the student satisfaction of new undergraduate international students enrolled at Panther University for Fall 2016. Responses from 115 first-semester undergraduate international students in the IAP (treatment group) were contrasted …
-
Role of caspases during inhibitor of apoptosis protein (IAP) inhibition
… this is through overexpression of endogenous IAPs, which are known to possess inhibitory functions within the apoptotic pathway and are often upregulated in specific types of cancer.<br><br>Recent studies have focused on the potential use of IAPs as therapeutic targets. The development of …
-
Solution structure and biochemistry of an intramembrane aspartyl protease (IAP)
… Through structure-function analysis of a model IAP from the archaeon Methanoculleus marisnigri JR1 (mIAP), the catalytic motifs and substrate gating motifs were found to influence the catalytic efficiency but not the processivity and specificity of cleavages. Both positional and chemical …
-
Immunomodulatory Effects of Inhibitor of Apoptosis (IAP) Antagonists on Dendritic Cells
The Inhibitor of Apoptosis (IAP) proteins are a highly conserved group of anti-apoptotic proteins that regulate various pathways, particularly those that affect proliferation and cell death. Smac mimetics compounds (SMCs) are IAP antagonists that induce the degradation of two IAPs, cellular IAP 1 …
-
Combination Immunotherapy with Inhibitor of Apoptosis (IAP) Antagonists to Treat Neuroblastoma
… anti-GD2 therapy. The Inhibitor of apoptosis (IAP) proteins are commonly upregulated in cancers and prevent cell death through the inhibition of caspases and through the control of NF-κB activity. Smac mimetic compounds (SMCs) have been designed to target IAP activity, thereby promoting cancer …
-
COMBINING IAP ANTAGONISTS WITH CAR T CELL THERAPY TO TREAT GLIOBLASTOMA: THE IAP ANTAGONIST BIRINAPANT ENHANCES CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR GLIOBLASTOMA BY OVERCOMING ANTIGEN HETEROGENEITY
… CAR T cells with inhibitor of apoptosis protein (IAP) antagonists, a new class of small molecules that mediate the degradation of IAPs, to treat GBM. Here, we demonstrated that the IAP antagonist birinapant could sensitize GBM cell lines and patient-derived primary GBM organoids to apoptosis …
-
Pre-clinical evaluation of inhibitors of apoptosis protein (IAP) antagonists in colorectal cancer
… important role. Inhibitor of apoptosis proteins (IAPs) are capable of converting TNFα signalling from a pro-apoptotic to a pro-survival and pro-inflammatory signal. Overexpression of IAPs is associated with chemoresistance and poor prognosis in CRC. Consequently, IAPs are an attractive target for …
-
The role of inhibitor of apoptosis (IAP) family member survivin in prostatic disease
… are less understood. The Inhibitor of Apoptosis (IAP) family member survivin has been found to be overexpressed during inflammation and associated with prostate cancer progression. Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional protein that is …
-
Type I Interferon-Mediated Killing of Cancer Cells with IAP-Targeted Combination Immunotherapy
… antagonists of the Inhibitor of Apoptosis (IAP) family of proteins. Binding of SMCs to the IAPs results in the sensitization of cancer cells to apoptosis in the presence of death ligands, such as tumour necrosis factor alpha (TNFα). I hypothesize that type I interferon (IFN) stimulation in …
-
Fine Mapping and Characterization of the iap Gene in Sorghum [Sorghum bicolor (L.) Moench]
… is greatly enhanced by the presence of the iap (Inhibition of Alien Pollen) allele. Hybridization between S. bicolor homozygous for iap and divergent species of sorghum and sugarcane (Saccharum spp.) has been demonstrated with introgression occurring in hybrids between S. bicolor and S. …
-
Investigating the Therapeutic Potential of IAP Antagonism for the Treatment of Duchenne Muscular Dystrophy
… the role of inhibitor of apoptosis proteins (IAPs), particularly cellular-IAPs 1 and 2 (cIAP1/2) in skeletal muscle pathology are increasingly recognized, their specific contribution to muscle fibrosis and the inflammatory response in DMD remains poorly understood. This study investigated the …
-
The Inhibitor of Apoptosis (IAP) Proteins Contribute to Acquired Chemotherapy Resistance in B-cell Neoplasms
The addition of rituximab to the therapeutic regimens used to treat B-cell non-hodgkin lymphoma (B-NHL) has improved patient response rates, but it has also alter the biology of the disease in the relapse/refractory setting. The patients that relapse after receiving induction therapy containing …
Page 1 of 15